Historical aspects and overview of research on phenylketonuria

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 5, Issue 2, 1999, Pages 101-103

  Koch, Richard ^a,c   De La Cruz, Felix ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Newborn screening; Phenylalanine; Phenylalanine hydroxylase; Phenylketonuria

Indexed keywords

BIOPTERIN; DIHYDROPTERIDINE REDUCTASE; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TYROSINE;

BLOOD LEVEL; DIET THERAPY; ENZYME DEFICIENCY; FAMILIAL DISEASE; GENE MUTATION; GENE THERAPY; HUMAN; HYPERPHENYLALANINEMIA; MEDICAL RESEARCH; MENTAL DEFICIENCY; MOUSE MUTANT; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY; TANDEM MASS SPECTROMETRY;

EID: 0033008781     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2779(1999)5:2<101::AID-MRDD1>3.0.CO;2-D     Document Type: Review

References (29)

1. Azen C, Koch R, Friedman EG, et al. 1991. Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child 145:35-57.
2. Bickel H, Gerard J, Hickmans EM. 1953. Influence of phenylalanine intake on phenylketonurics. Lancet 2:812-813.
3. Cleary M, Wraith JE, Jenkins JPR, et al. 1994. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87-90.
4. Cleary M, Walters JM, Wraith JR, et al. 1995. Magnetic resonance imaging in phenylketonuria and reversal of cerebral white matter change. J Pediatr 121:251-255.
5. DiSylvestre D, Koch R, Groffen J. 1991. Different clinical manifestations in three siblings with identical phenylalanine hydroxylase genes. Am J Hum Genet 48:1014-1016.
6. Dyken P, Culley W. 1969. Another population of PKU: studies on atypical phenylketonurics. Dev Med Child Neurol 11:718-729.
7. Eisensmith RC, Woo SLO. 1992. Molecular basis of phenylketonuria andrelated hyperphenylalaninemias; mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat 1:13-23.
8. Fisch R, Clung P, Weisberg S, et al. 1995. Phenylketonuric patients decades after diet. J Inherit Metab Dis; 18:426-427.
9. Fölling A. 1934 Euber Ausscheidung von Phenylbrueuztraubensaure inden harn als Staffweckselanormaloie in Verbindung met Imbezillitat. Z Physiol Chem 2L7:169-176.
10. Guthrie R. 1961. Blood screening for phenylketonuria. JAMA 178:863.
11. Guttler F, Guldberg P. 1996. Mutations in the phenylalanine hydroxylase gene: Phenotypic variability of hyperphenylalaninemia. Acta Paediatr Scand 407:49-56.
12. Holtzman NA, Kronmal RA, van Doorninck W, et al. 1986. Effect of ageat loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med 314:593-598.
13. Horner FH, Streamer CW, Alejandrino LL, et al. 1962. Report of three children taken off diet with no apparent ill effect. N Engl J Med 266:79-81.
14. Howell RR. 1970. PKU in the general population. N Engl J Med; 282:1486-1488.
15. Hsia DYY. 1966. PKU; a study of biochemical genetics. Pediatrics 38:173-184.
16. Hsia DYY, O'Flynn ME, Berman JL. 1968. Atypical PKU with borderline or normal intelligence. Am J Dis Child 116:143-157.
17. Jervis GA. 1947. Studies on phenylpyruvic oligophrenia: Position of metabolic error. J Biol Chem 169:651-656.
18. Kaufman S. 1971. The phenylalanine hydroxylating system from mammalian liver. Adv Enzymol 35:245-248.
19. Koch R, Azen C, Friedman EG, et al. 1996. Care of the adult with phenylketonuria. Eur J Pediatr 155(Suppl 1):590-592.
20. Koch R, Fishier K, Azen C, et al. 1997. The relationship of genotype to phenotype in phenylalanine hydroxylase deficiency. Biochem Mol Med 60:92-101.
21. Medical Research Council Working Party on Phenylketonuria. 1993. Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68:426-427.
22. Murphy D. 1969. Termination of dietary treatment of phenylketonuria. Ir J Med Sci 8:177-178.
23. Pietz J, Schmidt H, Meydig-Lamadz UR, et al. 1996. Phenylketonuria:Findings at MR imaging and localized in vivo H-1 spectroscopy of the brain in patients with early treatment. Radiology 201:413-420.
24. Scriver CR, Kaufman S, Eisensmith RC, et al. 1997. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly W, et al., editors. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw Hill: p 1015-1075.
25. Thompson AJ, Smith IL, Brenton D, et al. 1990. Neurological deterioration in young adults with phenylketonuria. Lancet 336:602-605.
26. Trefz FK, Brugard P, Konig T, et al. 1993. Genotype-phenotype correlation in phenylketonuria. Clin Chim Acta 217:15-21.
27. Udenfriend S, Cooper JR. 1953. Phenylalanine convention to tyrosine. J Biol Chem 194:503-511.
28. Ullrich K, Weglage J, Hahn-Ullrich H, et al. 1995. Magnetic resonance imaging and proton spectroscopy in PKU. Int Pediatr 10:95-99.
29. Weglage J, Moller H, Wiederman D, et al. 1998. In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of inter individual differences in brain phenylalanine concentrations. J Inher Metab Dis 21:81-82.